Effects of the aqueous extract of the of cinnamon zeylanicum barks (cinnamon)‎ on glucose, hemoglobin and lipid profile in alloxan : induced diabetic rats

Abstract EN

Cinnamonum zeylanicum (cinnamon) bark is considered extensively in the endogenous system of medicine as a drug for diabetes in many countries.

The current investigations focuses attention on the glucose and lipid lowering effect of the aqueous extract of Cinnamonum zeylanicum (cinnamon) barks on experimentally induced diabetes in rats.

The biochemical parameters studied were plasma glucose, insulin, total cholesterol, triglycerides, phospholipids, hemoglobin, and glycosylated hemoglobin.

In addition to measuring body weight, renal glucose reassertion was notified.

Aqueous extract of cinnamon barks were orally administered daily for 30 days in a dose of 100 mg / kg body weight to alloxan–diabetic rats, and a significant reduction in the parameters measured was investigated compared to diabetic rats, meanwhile, Glibinclamise was used as standard reference drug.

In conclusion cinnamon barks possess a hypoglycemic with concurrent hypolipidemic effect in diabetic states, and may further suggests that cinnamon parks may be useful in the therapy and managements of diabetic hyperlipidemia through reducing lipids levels.